Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Cytotoxic T Lymphocytes
100%
Methods for Detection
100%
Ex Vivo Expansion
100%
Lymphocyte Activity
25%
Peripheral Blood Lymphocytes
25%
Infected Individual
18%
T Lymphocyte Response
12%
B-lymphoblastoid Cell Lines
12%
Disease Stage
6%
CD4 Count
6%
Disease Progression
6%
Viremia
6%
51Cr Release Assay
6%
CD8+
6%
HIV-1 Gene
6%
Vaccinium
6%
Epstein-Barr Virus
6%
Vaccinia Virus
6%
In Vitro Activation
6%
UV Light
6%
Disease Therapy
6%
Acute HIV Infection
6%
Psoralen
6%
Selective Stimulation
6%
Expansion Method
6%
Direct Assay
6%
Medicine and Dentistry
T Lymphocyte
100%
Ex Vivo
100%
HIV Type 1
100%
Human Immunodeficiency Virus
43%
Lymphocyte
25%
B-Lymphoblastoid Cell Line
12%
Disease
6%
Disease Exacerbation
6%
Infection
6%
In Vitro
6%
Chromium Release Assay
6%
CD8 Antigen
6%
Combination Therapy
6%
Viremia
6%
Epstein Barr Virus
6%
Ultraviolet Radiation
6%
Human Immunodeficiency Virus 1 Infection
6%
Psoralen
6%
Vaccinia
6%
Vaccinia Virus
6%
Immunology and Microbiology
T Cell
100%
HIV Type 1
100%
Human Immunodeficiency Virus 1
50%
Peripheral Blood Lymphocyte
25%
B-Lymphoblastoid Cell Line
12%
CD4 Lymphocyte Count
6%
Viremia
6%
CD8
6%
Volume
6%
Epstein Barr Virus
6%
Vaccinium
6%
Vaccinia Virus
6%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
50%
Peripheral Blood Lymphocyte
25%
CD4 Lymphocyte Count
6%
Volume
6%
Vaccinium
6%
CD8
6%
Epstein Barr Virus
6%
Viremia
6%
Vaccinia Virus
6%